医学
传统PCI
药物治疗
冠状动脉疾病
经皮冠状动脉介入治疗
心脏病学
内科学
疾病
冠心病
重症监护医学
冠心病
心肌梗塞
作者
William E. Boden,Robert A. O’Rourke,Koon Teo,Pamela Hartigan,David J. Maron,William J. Kostuk,Merril L. Knudtson,Marcin Dada,Paul Casperson,Crystal L. Harris,Bernard Chaitman,Leslee J. Shaw,Carlos Peña,Anita Panda,Lawrence Title,Gerald T. Gau,Alvin Blaustein,David C. Booth,Eric Bates,John A. Spertus,Daniel S. Berman,G.B. John Mancini,William S. Weintraub
摘要
In patients with stable coronary artery disease, it remains unclear whether an initial management strategy of percutaneous coronary intervention (PCI) with intensive pharmacologic therapy and lifestyle intervention (optimal medical therapy) is superior to optimal medical therapy alone in reducing the risk of cardiovascular events.
科研通智能强力驱动
Strongly Powered by AbleSci AI